are histologically and biologically different from reactive fibrosis or the proliferation of fibroblasts that occurs, for example, in decubitus ulcer and scar tissues. The incidence of desmoid tumors in the general population is markedly low, representing less than 0.1% of all the tumors and 3.5% of all fibrous tumors (MacAdam and Goligher 1970; Reitamo et al. 1982) . The cause of desmoid tumors is still uncertain and may be related to trauma or hormonal factors, or may be associated with genetic predisposition. Desmoid has been reported in association with familial adenomatous polyposis (FAP), especially with Gardner's syndrome (Gardner and Richards 1953) . Desmoid tumors are also classified according to the site of occurrence into extra-abdominal or intra-abdominal (Musgrove and McDonald 1948) and abdominal desmoid tumors (Goldblum and Fletcher 2002) . In addition, different biological behaviors between sporadic tumors and FAP-associated ones have been postulated (Clark and Phillips 1996) . Desmoid tumors are generally benign and have no potential to develop metastatic disease. However, they can be locally invasive and destructive to adjacent normal tissues and structures (Kasukawa et al. 1999) , which makes complete surgical excision very difficult, resulting in frequent recurrence in such the patients.
Sex steroids have been considered to play some role in the development of soft tissue lesions such as lymphangioleiomyomatosis (Sullivan 1998) . Therefore, several investigators have examined the presence of sex steroid receptors in desmoid tumors. Sex steroids exert many of their effects through interaction with an intracellular receptor protein, which is a transcriptional activator (Beato and Klug 2000) . It is therefore important to study the expression of sex steroid receptors for determining the biological actions of sex steroids in sex steroid-dependent tissues. Expression of estrogen receptors (ER) has been reported in 25 to 75% of desmoid tumors (Lim et al. 1986; Alman et al. 1992) , but the absence of estrogen receptors in such tumors has also been reported (Fong et al. 1993; Serpell et al. 1999; Sorensen et al. 2002) . Progesterone receptors (PR) have been reported to be present in desmoid tumors by several investigators Fong et al. 1993 ), but no consistent results have been reported. In contrast, the androgen receptor (AR) has not been examined at all in desmoid tumors. Therefore, in this study, we examined the expression of ERα , ERβ , PRA, PRB and AR by reverse transcription and polymerase chain reaction (RT-PCR) and immunohistochemistry in desmoid tumors and reactive self-limiting lesions associated with fibrosis as a control in order to study the possible involvement of sex steroids in the clinical or biological features of desmoid tumors.
MATERIALS AND METHODS

Tissue samples
Tissue samples for immunohistochemical study were obtained from twenty-seven patients with primary extra-abdominal and abdominal desmoid tumors. The sites of occurrence were the neck in one patient, the upper extremity in one patient, the chest wall in two patients, the back in seven patients, the lower extremity in ten patients, and the abdominal wall in six patients. No mesenteric (intra-abdominal) desmoid tumors were included. Of these twenty-seven, 8 were males and 19 were females and their ages at the time of diagnosis ranged from 13 to 72 years (37 ± 11 years) ( Table 1) . For RT-PCR analysis, fresh frozen desmoid tissues were obtained from eight of the twenty-seven patients, 2 males and 6 females (33 ± 14 years). None of the desmoid tumors were associated with FAP or Gardner's syndrome. Reactive lesions associated with fibrosis, but showing no inflammation, were obtained from decubitus ulcer and scar tissues of 6 males and 2 females, means 46 ± 11 years old. All of these tissues were examined by both RT-PCR and immunohistochemistry. For RT-PCR study, these tissue samples were dissected into small pieces, frozen in liquid nitrogen and stored at -80°C. All specimens for immunohistochemical examination were fixed in 10% neutral formalin for 18h at room temperature and embedded in paraffin. These specimens were subsequently sectioned at 3 μ m and mounted on silane-coated glass slides (Matsunami Co. Ltd., Tokyo). This investigation was approved by the Ethics Committee on Human Study at Tohoku University School of Medicine (2002-168B) .
Immunohistochemistry
The monoclonal antibody for ERα (NCL-ER-6F11) was obtained from Novocastra Laboratories (Newcastle, United Kingdom) and that for ERβ (06-629) was obtained from Genetex Biotechnology. Monoclonal antibodies for two isoforms of PR-A (hPRa 7) and PR-B (hPRa 2) were purchased from NeoMarkers (Fremont, CA, USA). These antibodies were raised in mouse against PR isoforms obtained from a human endometrial carcinoma (EnCa 101). PR-A and PR-B differ in that the PR-B protein contains an additional squence of at its amino terminus (Kastner et al. 1990 ). The hPRa2 antibody recognizes only the PR-B receptor isoform, whereas the hPRa7 antibody employed in this study recognizes PR-A in 10% formalin-fixed and paraffin-embedded tissue specimens even following antigen retrieval (Mote et al. 1999) . Monoclonal antibody for AR (AR411) was obtained from DAKO Corp (Carpinteria, CA, USA).
Immunohistochemical staining was performed using the streptavidin-biotin amplification method with a Histofine Kit (Nichirei, Tokyo). Details of the immunohistochemical procedures used in this study were previously described (Ishizuka et al. 2004) . Antigen retrieval for all the receptors was performed using autoclave treatment at 120°C for 5 min. Dilutions of the primary antibodies used in our study were as follows: ERα , 1 : 50; ER β , 1 : 50; PR-A, 1 : 200; PR-B, 1 : 200; and AR, 1 : 100. The antigen-antibody complex was visualized with 3,3'-diaminobenzidine (DAB) solution (1 mM DAB, 50 mM Tris-HCl buffer [pH 7.6], and 0.006% H 2 O 2 ), and counterstained with hematoxylin. Tissue sections of an invasive ductal carcinoma of the breast were used as positive controls for ERα , ERβ , PR-A, PR-B and normal prostate tissue were used as a positive control for AR. As a negative control, normal rabbit or mouse IgG was used instead of the primary antibodies. No specific immunoreactivity was detected in these tissue sections. Two of the authors initially determined the fields simultaneously using a double-headed light microscope. The evaluation of ERα , ERβ , PR-A, PR-B and AR positive cells was performed on high-power fields (× 400) using a standard light microscope. Only distinctive intranuclear immunoreactivity was considered positive. In each case, more than 500 cells were counted and the percentage of immunoreactivity was independently determined. When interobserver differences were greater than 5%, the immunostained slides were re-examined simultaneously using a double-headed light microscope and the percentage of positive cells was determined. When interobserver differences were less than 5%, the mean value was obtained as the positive rate. When more than 10% positive cells were detected, the case was considered positive.
RT-PCR
Total RNA was extracted from frozen samples using TRIzol reagent (Invitrogen, Tokyo). The RNA concentrations were determined spectrophotometrically. Total RNA (2 μ g) was denatured at 70°C for 10 min and then reverse transcribed using oligo (dT) primers and SuperScript II reverse transcriptase (Invitrogen) in a final reaction volume of 20 μ l at 42°C for 60 min. The reaction was terminated by heating at 70°C for 15 min. Real- 13.4 μ l water, 1.6 μ l MgCl 2 (3 mM), 1.0 μ l forward primer (1.0 μ M), 1.0 μ l reverse primer (1.0 μ M) and 2.0 μ l the LightCycler FastStart DNA Master SYBR Green I. Nineteen microliters of master mix was introduced into the glass capillaries and 20 ng cDNA in 1 μ l were added as PCR template. The primer sequences and optimal variables used in this study are listed in Table 1 (Greene et al. 1986; Tokunaga et al. 1987; Chang et al. 1988; Kastner et al. 1990; Ogawa et al. 1998) . Gene specific primers for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as an internal control. To avoid amplification of any genomic DNA, the forward and reverse primers for each gene were chosen from different exons. An initial denaturing step at 95°C for 10 min was followed by 40 cycles of denaturing at 95°C for 15 sec, annealing at optimal temperature (ERα , 62°C; ERβ , 66°C; PR, 70°C and AR, 66°C) for 10 sec and extension at 72°C for 8 sec (PR) or 10 sec (ERα , ERβ and AR). PR is represents PR-A and/or PR-B, and the primers employed could detect both PR-A and PR-B mRNAs. Real-time PCR monitoring was achieved by measuring the fluorescent signal at the end of the annealing phase for each cycle. Each run consisted of 5 external standards, a negative control without a template and patient samples with unknown mRNA concentrations. External standards for these receptor mRNAs were prepared by 5-fold serial dilutions of positive control cDNA. As a positive control, frozen tissues of breast carcinoma were used for ERα , ERβ and PR and those of normal testis were used for AR. Following RT-PCR, the reaction products were resolved on a 2%-agarose gel by electrophoresis. Gels were stained with ethidium bromide to visualize the PCR product size. Negative control experiments lacked the cDNA substrate to check for the possibility of exogenous contaminant DNA. No amplified products were detected under these conditions.
RESULTS Immunohistochemistry
The results of immunohistochemistory of sex steroid receptors were summarized in Table 2 . ERα and ERβ immunoreactivities were detected in 7.4% and 7.4% of the desmoid tumors, respectively, PR-A and PR-B in 25.9% and 33.3%, respectively, and AR in 52.9% of the desmoid tumors (Fig. 1) . PR-A and PR-B were simultaneously detected in six cases of these desmoid tumors (3 males and 3 females). AR immunoreactivity was detected in reactive fibrosis (37.5%). None of the eight reactive fibrosis cases demonstrated ERs or PRs immunoreactivities (Fig. 2) ( Table 3 ). There were no statistically significant correlations between the immunoreactivity and the sex or age of the patients in the desmoid tumors or reactive fibrosis.
RT-PCR study
RT-PCR analysis demonstrated the expression of PR and AR mRNAs in all eight desmoid tumors and reactive fibrosis tissues. The examined desmoids are No. 4, 5, 6, 7, 13, 18, 19 and 21 in Table 2 . No mRNA expression for ERα and ERβ was detected in any desmoid tumors and reactive fibrosis tissues (Fig. 3) . PCR samples, No. 1, 2, 3, 4, 5, 6, 7 and 8, correspond to case No. 18, 4, 5, 7, 6, 19, 21 and 13 in Table 2 , respectively.
DISCUSSION
An association of desmoid tumors with the endogenous hormonal environment, especially that of sex hormones has been proposed by several investigators. These tumors occur in all age groups but the hormonal influence especially that of sex steroids, has been proposed as one of the most important factors associated with the onset of desmoid tumors . McAdam and Goligher (1970) suggested that the growth of desmoid tumors is stimulated by estrogens, based on a higher incidence of their occurrence in women of childbearing age and their association with pregnancy. Lipschutz and Grismail (1944) and others (Nadel 1950; Jadrivevic et al. 1956 ) induced abdominal wall desmoid tumors in experimental animals by injecting them with high-dose estrogen pellets. This possible dependency of desmoid tumors on sex steroids, especially estrogens, may lead to new insights on the biological behavior of desmoid tumors including their development and proliferation, and also to the possible use of a novel hormonal treatment for managing the postoperative recurrence of desmoid tumors. The desmoid tumors examined in this study arose in extra-abdominal sites, which are the most common sites of desmoid tumors. In our study none of the desmoid tumors examined expressed ERs mRNA in the RT-PCR analysis. Serpell et al. (1999) also reported the absence of ERs and PRs in a series of desmoid tumours. Therefore, estrogen itself is not considered to play an important role in the biological behavior of this tumor, at least in desmoid tumors arising in extra-abdominal sites. Several cases of desmoid tumors have been reported to undergo regression after treatment with progestational agents (Lanari 1983; Eagel et al. 1989; Wilcken and Tattersall 1991) . Fibrous tumors were experimentally induced in guinea pig treated with estrogens, and regression occurred when the hormonal therapy was suspended or followed by treatment with progesterone and testosterone (Lipschutz and Grismail 1944) . The treatment of desmoid tumors with progesterone has also been reported by several authors (Lipschutz and Grismail 1944; Nadel 1950; Dahn et al. 1963; Lanari 1983 ). Clinically, pregnancy has been well-known to ameliorate the course of abdominal desmoid tumors (Ober et al. 1955; McDougall and McGarrity 1979; Way and Culham 1999) . This clinical observation has raised questions concerning the most appropriate hormonal treatment for these tumors.
In our present study, PR mRNA was detected in both 8 desmoid tumors and 8 reactive lesions. In the immunohistochemical study, 25.9% of the desmoid tumors were positive for PR-A and 33.3% for PR-B. Alman et al. (1992) examined cases of aggressive fibromatosis of the extremities for the presence of estrogen and progesterone receptors and for the expression of the c-sis oncogene and platelet-derived growth factor (PDGF), potent mitogens for fibrocytes. They also reported about two thirds of the tumors examined expressed ERs or PRs. All tumors examined were associated with the over-expression of c-sis and PDGF. This over-expression may be responsible 4, 5, 6, 7, 13, 18, 19 and 21 in Table 2 . Bands of the correct size for PR, AR and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were detected in all the desmoid tumor and reactive fibrosis samples. ERα and ERβ were not detected in all the examined samples. PCR No. 1, 2, 3, 4, 5, 6, 7 and 8 correspond to case No. 18, 4, 5, 7, 6, 19, 21 and 13 in Table 2 , respectively. PC, positive controls. NC, negative controls.
for the underlying pathobiology and uncontrolled growth in aggressive fibromatosis. Progesterone has been considered to inhibit the proliferation of desmoid tumors but further investigations are required to clarify the detailed involvement of progesterone in the biological behavior of desmoid tumors, because extra-abdominal desmoid tumors most frequently occur in the anterior abdominal wall, typically in females of childbearing age when serum progesterone levels were elevated (Musgrove and McDonald 1948; Dahn et al. 1963; McDougall and McGarrity 1979; Reitamo et al. 1982) . In our present study, PR immunoreactivity was detected only in desmoid tumors, which suggests that PR expression is more pronounced in desmoid than in reactive fibrosis. Testosterone has been clinically employed in the treatment of recurrent extra-abdominal tumors (Waddell 1975) , but AR expression in desmoid tumors has not been reported in the literature. In our present study, AR expression was demonstrated by both RT-PCR and immunohistochemistry. We also detected AR mRNA, but few cases demonstrated AR immunoreactivity in granulation tissue obtained from reactive fibrosis. Therefore, the present study indicates that reactive fibrosis has less functional AR than do desmoid tumors. Considering the clinical efficacy of androgen treatment in controlling recurrent desmoid tumors, androgen may provide inhibitory effects on desmoid tumors.
